Results 1 to 10 of about 50,272 (136)

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice [PDF]

open access: yesiScience, 2023
Summary: The liver coordinates the systemic response to nutrient deprivation and availability by producing glucose from gluconeogenesis during fasting and synthesizing lipids via de novo lipogenesis (DNL) when carbohydrates are abundant.
Nicole K.H. Yiew   +12 more
doaj   +2 more sources

Structure of human mitochondrial pyruvate carrier MPC1 and MPC2 complex [PDF]

open access: yesNature Communications
The Mitochondrial Pyruvate Carrier (MPC) bridges cytosolic and mitochondrial metabolism by transporting pyruvate into mitochondria for ATP production and biosynthesis of various essential molecules.
Yingyuan Sun   +9 more
doaj   +2 more sources

NMR and Patch-Clamp Characterization of Yeast Mitochondrial Pyruvate Carrier Complexes [PDF]

open access: yesBiomolecules, 2023
The mitochondrial pyruvate carrier (Mpc) plays an indispensable role in the transport of pyruvates across the mitochondrial inner membrane. Despite the two distinct homologous proteins, Mpc1 and Mpc2, were identified in 2012, there are still ...
Zhen Wang   +8 more
doaj   +2 more sources

Association of Mitochondrial Pyruvate Carrier with the Clinical and Histological Features in Lupus Nephritis [PDF]

open access: yesInternational Journal of Nephrology and Renovascular Disease
Huanhuan Zhu, Chen Chen, Luhan Geng, Qing Li, Chengning Zhang, Lin Wu, Bo Zhang, Suyan Duan,* Changying Xing,* Yanggang Yuan* Department of Nephrology, the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University ...
Zhu H   +9 more
doaj   +2 more sources

The Multifaceted Pyruvate Metabolism: Role of the Mitochondrial Pyruvate Carrier [PDF]

open access: yesBiomolecules, 2020
Pyruvate, the end product of glycolysis, plays a major role in cell metabolism. Produced in the cytosol, it is oxidized in the mitochondria where it fuels the citric acid cycle and boosts oxidative phosphorylation.
Joséphine Zangari   +3 more
doaj   +2 more sources

Branched-chain keto acids inhibit mitochondrial pyruvate carrier and suppress gluconeogenesis in hepatocytes [PDF]

open access: yesCell Reports, 2023
Summary: Branched-chain amino acid (BCAA) metabolism is linked to glucose homeostasis, but the underlying signaling mechanisms are unclear. We find that gluconeogenesis is reduced in mice deficient of Ppm1k, a positive regulator of BCAA catabolism, which
Kiyoto Nishi   +10 more
doaj   +2 more sources

Key features of inhibitor binding to the human mitochondrial pyruvate carrier hetero-dimer [PDF]

open access: yesMolecular Metabolism, 2022
Objective: The mitochondrial pyruvate carrier (MPC) has emerged as a promising drug target for metabolic disorders, including non-alcoholic steatohepatitis and diabetes, metabolically dependent cancers and neurodegenerative diseases.
Sotiria Tavoulari   +8 more
doaj   +2 more sources

The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease [PDF]

open access: yesBiomolecules, 2023
Pyruvate sits at an important metabolic crossroads of intermediary metabolism. As a product of glycolysis in the cytosol, it must be transported into the mitochondrial matrix for the energy stored in this nutrient to be fully harnessed to generate ATP or
Kyle S. McCommis, Brian N. Finck
doaj   +2 more sources

Insights on the Quest for the Structure–Function Relationship of the Mitochondrial Pyruvate Carrier [PDF]

open access: yesBiology, 2020
The molecular identity of the mitochondrial pyruvate carrier (MPC) was presented in 2012, forty years after the active transport of cytosolic pyruvate into the mitochondrial matrix was first demonstrated.
José Edwin Neciosup Quesñay   +8 more
doaj   +2 more sources

UK5099 Inhibits the NLRP3 Inflammasome Independently of its Long‐Established Target Mitochondrial Pyruvate Carrier [PDF]

open access: yesAdvanced Science
Targeting NLRP3 inflammasome has been recognized as a promising therapeutic strategy for the treatment of numerous common diseases. UK5099, a long‐established inhibitor of mitochondrial pyruvate carrier (MPC), is previously found to inhibit macrophage ...
Linyu Ran   +12 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy